Logo

survey

NGS Results Led to Treatment Change for 16 Percent of Cancer Patients, Study Finds
Premium

The researchers also surveyed treating oncologists about why they decided to change, or not change, the treatment approach.

Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines
Premium

An IASLC survey showed that molecular testing is not performed in line with expert guidelines, which means only a minority of lung cancer patients are benefitting from precision oncology.

Delayed Testing, Limited Patient Understanding May Hinder Precision Oncology Access, Survey Suggests
Premium

The survey results point to the need for greater education among patients so they can better advocate for themselves.

2018 GenomeWeb Salary Survey

Respondents to GenomeWeb's salary survey reported variations in their salaries that varied by sector.

Survey Finds QC Best Practices in Clinical Genomics Still Developing

The survey, conducted by SeraCare Life Sciences and GenomeWeb, asked more than 150 individuals working on clinical NGS about their quality control practices.

May 23, 2018

Public Awareness of Personalized Medicine Not Growing in Step With Industry, Survey Shows

Jan 5, 2018

Illumina Remains NGS Leader But Competitors Expected to Gain, Survey Finds
Premium

Oct 19, 2017

In Stanford Survey, Majority of Genetics Professionals Supports Human Gene Editing

May 2, 2017

Oncologists Often Favor Immunotherapy Over NGS-Guided Targeted Drugs, Survey Finds
Premium

May 2, 2017

In Survey, Oncologists See Genomic Testing as Important Advance, But Value 'Below Expectations'

Jul 15, 2016

Appetite for Sequencing, Additional Instruments Remains High Among NGS Users, Survey Finds
Premium

May 12, 2016

Consumer Genomics Awareness High but Market Still Nascent, Survey Shows
Premium

Mar 1, 2016

Consumer Perceptions May Influence Satisfaction With Physician Discussion of DTC Genetic Testing Results

Aug 14, 2015

Survey Explores Provider Attitudes on Who Should Act on Patients' PGx Testing Results
Premium

May 20, 2015

Pharma's Personalized Medicine Investment Remains Steady; Science a Major Hurdle, Tufts Report Shows
Premium

Apr 27, 2015

Survey Shows More NSCLC Patients Getting EGFR Testing, but Results Often Don't Inform Care
Premium

Apr 21, 2015

Survey Finds High Interest in Long-Range Genome Data, Nanopore Tech While Illumina Rules NGS Market
Premium

Mar 31, 2015

Study Shows Consumers Get Basic Genetic Concepts after DTC Testing; Can they Explain it to Another?
Premium

Jan 22, 2013

Genomic Researchers See Flat Array Spending in 2013; Decline in Expression Array Usage
Premium

Jan 22, 2013

Researchers Rank MiSeq over PGM for Usability; Expect Their Sequencing Output to Grow by Half in 2013
Premium

Jan 16, 2013

Goldman Sachs Survey Finds Spending on Life Science Tools Remains Challenged by Funding, Fiscal Concerns

Oct 25, 2012

Survey Indicates Life Tech Remains Leader of qPCR Research Market, But Faces Some Pricing Pressure
Premium

Oct 2, 2012

In Sequence Survey: Illumina Holds Two-Thirds of Sequencing Market, Splits Desktop Share with Ion PGM
Premium

Jul 31, 2012

Researchers Foresee 40 Percent Increase in Sequenced Human Genomes in 2013
Premium

Jul 30, 2012

Funding Optimism Grows Among Genomics Researchers, Mizuho Survey Finds